+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oncology NGS Market - Global Forecast 2026-2032- Product Image
Oncology NGS Market - Global Forecast 2026-2032- Product Image
New

Oncology NGS Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715540
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oncology next-generation sequencing (NGS) market is undergoing significant transformation, shaped by fast-evolving technologies, growing demand for precision oncology, and increasingly complex operational and regulatory requirements. Senior decision-makers must anticipate disruptive shifts to succeed in this dynamic environment.

Market Snapshot

The Oncology NGS Market grew from USD 4.01 billion in 2025 to USD 4.58 billion in 2026 and is projected to reach USD 10.85 billion by 2032, expanding at a CAGR of 15.27%. This growth is propelled by rapid adoption of sequencing platforms in clinical diagnostics, increasing integration with drug development pipelines, and heightened focus on precision medicine. Market expansion is further influenced by evolving regulatory frameworks, changes in global trade policies, and the growing diversity of clinical research and diagnostic applications.

Scope & Segmentation

  • Product Types: Benchtop sequencers for decentralized labs, high-throughput platforms for centralized centers, and a broad range of reagents, including flow cells, library preparation kits, and sequencing kits.
  • Services: Data analysis supporting panel, RNA, and whole exome assays; sample preparation enabling workflow reproducibility and assay reliability.
  • Cancer Indications: Coverage across breast, lung, colorectal, and hematological cancers—each with distinct clinical testing requirements and strategic priorities.
  • Applications: Routine clinical panels, RNA sequencing for transcriptomics, and whole exome sequencing for complex diagnostics and research initiatives.
  • End Users: Academic research institutes, diagnostic laboratories, hospitals, and pharmaceutical and biotechnology companies with diverse workflow demands.
  • Regions: Americas (advanced clinical infrastructure and translational research), EMEA (regulatory diversity and mixed adoption models), Asia-Pacific (rapid capacity expansion and central lab development).
  • Technologies: Platform performance, reagent innovation, integrated informatics, and scalable bioinformatics pipelines as core industry drivers.

Key Takeaways

  • Technological maturation of NGS platforms has lowered adoption barriers, allowing both decentralized clinics and high-capacity labs to tailor solutions to local needs.
  • Innovation in reagents and sample preparation has improved assay sensitivity while reducing operational complexity for laboratories.
  • End-to-end service models—including certified data analysis and workflow integration—are central to winning contracts and building lasting partnerships.
  • Segmentation across product, cancer type, application, and end-user highlights highly differentiated value pools and requires bespoke go-to-market and support strategies.
  • Regional differences in infrastructure, reimbursement, and regulatory requirements directly shape deployment patterns, commercial models, and partnership choices.
  • Validated workflows, recurring service revenues, and robust technical support are becoming essential for sustainable growth and customer retention.

Tariff Impact

New tariffs and trade policy adjustments implemented in 2025 have created operational headwinds within oncology NGS. Procurement teams reacted by diversifying suppliers, adjusting inventory practices, and prioritizing platforms and consumables less exposed to cross-border logistics risks. Diagnostic labs and hospital systems have consolidated orders and restructured batch sizes to manage rising costs, while service providers reviewed pricing and adjusted their supply chain models. The ongoing policy volatility highlights the importance of flexible procurement contracts and dynamic supply chain management to protect clinical operations and maintain patient care continuity.

Methodology & Data Sources

This analysis is based on a rigorous mixed-methods research process. We combined structured interviews with executives in platform manufacturing, reagent development, and laboratory leadership, alongside expert consultations, peer-reviewed literature reviews, and critical regulatory document analysis. Data points were technically validated through cross-referencing published studies, product manuals, and regulatory filings to ensure accuracy and transparency.

Why This Report Matters

  • Identify actionable strategies for platform adoption, market positioning, and response to regulatory and policy shifts in oncology NGS.
  • Understand segmentation-driven value pools and align operational initiatives with high-impact clinical and commercial opportunities.
  • Gain clarity on procurement, supply chain, and partnership dynamics that shape competitive advantage and long-term sustainability in this market.

Conclusion

Oncology NGS is entering a pivotal period, marked by innovation, operational complexity, and increasing regulatory scrutiny. Organizations that align validated workflows with robust bioinformatics and resilient supply chains will maximize clinical and commercial value in the years ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Oncology NGS Market, by Product Type
8.1. Instruments
8.2. Reagents & Consumables
8.2.1. Library Preparation Kits
8.2.2. Sequencing Reagents
8.2.3. Target Enrichment Kits
8.3. Services
8.3.1. Bioinformatics & Data Analysis Services
8.3.2. Clinical Reporting & Interpretation Services
9. Oncology NGS Market, by Cancer Type
9.1. Solid Tumors
9.1.1. Breast Cancer
9.1.2. Lung Cancer
9.1.3. Colorectal Cancer
9.1.4. Prostate Cancer
9.1.5. Ovarian Cancer
9.1.6. Melanoma
9.2. Hematologic Malignancies
9.2.1. Leukemia
9.2.2. Lymphoma
9.2.3. Myeloma
10. Oncology NGS Market, by Technology
10.1. Whole Genome Sequencing
10.2. Whole Exome Sequencing
10.3. Targeted Sequencing & Resequencing
11. Oncology NGS Market, by Sample Type
11.1. Tissue Samples
11.1.1. Formalin-Fixed Paraffin-Embedded Tissue
11.1.2. Fresh Frozen Tissue
11.2. Liquid Biopsy Samples
11.2.1. Plasma
11.2.2. Serum
11.2.3. Circulating Tumor Cells
12. Oncology NGS Market, by Workflow Stage
12.1. Pre-Sequencing
12.2. Sequencing
12.3. Data Analysis
13. Oncology NGS Market, by Application
13.1. Clinical Diagnostics
13.1.1. Solid Tumor Profiling
13.1.2. Hematologic Malignancy Profiling
13.1.3. Germline Cancer Predisposition Testing
13.1.4. Minimal Residual Disease Monitoring
13.1.5. Companion Diagnostics
13.2. Research
13.2.1. Oncology Biomarker Discovery
13.2.2. Tumor Heterogeneity Studies
13.2.3. Resistance Mechanism Studies
13.3. Drug Development
13.4. Liquid Biopsy
13.4.1. Early Cancer Detection
13.4.2. Treatment Response Monitoring
13.4.3. Recurrence Surveillance
14. Oncology NGS Market, by End User
14.1. Academic & Research Institutions
14.2. Hospitals & Cancer Centers
14.2.1. Oncology Departments
14.2.2. Pathology Laboratories
14.3. Clinical Diagnostic Laboratories
14.4. Pharmaceutical & Biotechnology Companies
14.5. Contract Research Organizations
15. Oncology NGS Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Oncology NGS Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Oncology NGS Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Oncology NGS Market
19. China Oncology NGS Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Agilent Technologies, Inc.
20.6. BGI Group
20.7. Bio-Rad Laboratories, Inc.
20.8. Burning Rock Dx
20.9. Creative Biogene
20.10. DH Life Sciences, LLC
20.11. Eurofins Scientific S.E.
20.12. Exact Sciences Corporation
20.13. F. Hoffmann-La Roche Ltd
20.14. Genecast Group Inc.
20.15. Guardant Health, Inc.
20.16. Hologic, Inc.
20.17. Illumina, Inc.
20.18. Invivoscribe, Inc.
20.19. Myriad Genetics, Inc.
20.20. Oxford Nanopore Technologies plc.
20.21. Pacific Biosciences of California, Inc.
20.22. PerkinElmer Inc.
20.23. Personalis, Inc.
20.24. Promega Corporation
20.25. Qiagen N.V.
20.26. seqWell
20.27. SOPHiA GENETICS.
20.28. Takara Bio Inc.
20.29. Tecan Trading AG
20.30. Thermo Fisher Scientific, Inc.
20.31. Twist Bioscience Corporation
List of Figures
FIGURE 1. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES ONCOLOGY NGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA ONCOLOGY NGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BIOINFORMATICS & DATA ANALYSIS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL REPORTING & INTERPRETATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL REPORTING & INTERPRETATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL REPORTING & INTERPRETATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ONCOLOGY NGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ONCOLOGY NGS MARKET SIZE, BY OVARIAN CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ONCOLOGY NGS MARKET SIZE, BY OVARIAN CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MELANOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MELANOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LEUKEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LYMPHOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MYELOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MYELOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MYELOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED SEQUENCING & RESEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED SEQUENCING & RESEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED SEQUENCING & RESEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRE-SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRE-SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMOR PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMOR PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SOLID TUMOR PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCY PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCY PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCY PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GERMLINE CANCER PREDISPOSITION TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GERMLINE CANCER PREDISPOSITION TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GERMLINE CANCER PREDISPOSITION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ONCOLOGY NGS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ONCOLOGY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ONCOLOGY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ONCOLOGY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TUMOR HETEROGENEITY STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TUMOR HETEROGENEITY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TUMOR HETEROGENEITY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESISTANCE MECHANISM STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESISTANCE MECHANISM STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RESISTANCE MECHANISM STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ONCOLOGY NGS MARKET SIZE, BY EARLY CANCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ONCOLOGY NGS MARKET SIZE, BY EARLY CANCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ONCOLOGY NGS MARKET SIZE, BY EARLY CANCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TREATMENT RESPONSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TREATMENT RESPONSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TREATMENT RESPONSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RECURRENCE SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RECURRENCE SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RECURRENCE SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ONCOLOGY DEPARTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ONCOLOGY DEPARTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ONCOLOGY DEPARTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PATHOLOGY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PATHOLOGY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 187. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 188. AMERICAS ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 254. EUROPE ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. EUROPE ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. EUROPE ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 257. EUROPE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 258. EUROPE ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 259. EUROPE ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 260. EUROPE ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 261. EUROPE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. EUROPE ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 263. EUROPE ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 264. EUROPE ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 265. EUROPE ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 266. EUROPE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. EUROPE ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 268. EUROPE ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 269. EUROPE ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 270. EUROPE ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. EUROPE ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 280. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 281. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 282. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 283. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 290. AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 292. AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 293. AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 294. AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 295. AFRICA ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 296. AFRICA ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 297. AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 298. AFRICA ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 299. AFRICA ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 300. AFRICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 301. AFRICA ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 302. AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. AFRICA ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 304. AFRICA ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 305. AFRICA ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 306. AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 307. AFRICA ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 308. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 309. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 310. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 311. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 312. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 313. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 314. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 315. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 316. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 317. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
TABLE 318. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY SAMPLES, 2018-2032 (USD MILLION)
TABLE 319. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 320. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 321. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 322. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 323. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY LIQUID BIOPSY, 2018-2032 (USD MILLION)
TABLE 324. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 325. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CANCER CENTERS, 2018-2032 (USD MILLION)
TABLE 326. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 327. ASEAN ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 328. ASEAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 329. ASEAN ONCOLOGY NGS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 330. ASEAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 331. ASEAN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 332. ASEAN ONCOLOGY NGS MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 333. ASEAN ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, 2018-2032 (USD MILLION)
TABLE 334. ASEAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 335. ASEAN ONCOLOGY NGS MARKET SIZE, BY SAMPLE TYPE,

Companies Mentioned

The key companies profiled in this Oncology NGS market report include:
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Burning Rock Dx
  • Creative Biogene
  • DH Life Sciences, LLC
  • Eurofins Scientific S.E.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Genecast Group Inc.
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Personalis, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • seqWell
  • SOPHiA GENETICS.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corporation

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.58 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.85 Billion
Compound Annual Growth Rate15.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2025 - Product Image

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Next-Generation Sequencing (NGS) in Precision Medicine Market Report 2025 - Product Image

Next-Generation Sequencing (NGS) in Precision Medicine Market Report 2025

  • Report
  • 250 Pages
  • Global
From
NGS-Based RNA-Sequencing Market - Global Forecast 2026-2032 - Product Image

NGS-Based RNA-Sequencing Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
NGS Library Preparation Market - Global Forecast 2026-2032 - Product Image

NGS Library Preparation Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report - Product Image

Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

  • Report
  • 206 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.